Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox)
- 1 July 2002
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 90 (1), 42-45
- https://doi.org/10.1016/s0002-9149(02)02384-6
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- The impact of body mass index onshort- and long-term outcomes inpatients undergoing coronary revascularizationJournal of the American College of Cardiology, 2002
- Body-Mass Index and Mortality in a Prospective Cohort of U.S. AdultsThe New England Journal of Medicine, 1999
- Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockadeThe Lancet, 1998
- Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary RevascularizationThe New England Journal of Medicine, 1997
- Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-IIThe Lancet, 1997
- Low-Normal or Excessive Body Mass Index: Newly Identified and Powerful Risk Factors for Death and Other Complications With Percutaneous Coronary InterventionThe American Journal of Cardiology, 1996
- Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary AngioplastyThe New England Journal of Medicine, 1994
- Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinaseJournal of the American College of Cardiology, 1988
- Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapyThe American Journal of Medicine, 1987